{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:32:08Z","timestamp":1793946728452,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.diabres.2026.113280","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T14:40:23Z","timestamp":1777214423000},"page":"113280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Beyond HbA1c: Albumin-corrected fructosamine is associated with diabetic retinopathy in well-controlled type 2 diabetes"],"prefix":"10.1016","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0305-9430","authenticated-orcid":false,"given":"Qiyun","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9589-9465","authenticated-orcid":false,"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.diabres.2026.113280_b0005","first-page":"e144","volume":"9","author":"Gbd","year":"2021","journal-title":"Glob Health"},{"issue":"2","key":"10.1016\/j.diabres.2026.113280_b0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.mayocp.2020.07.031","article-title":"Four-year screening interval and vision-threatening retinopathy in type 2 diabetes patients with good glycemic control","volume":"96","author":"Tsujimoto","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.diabres.2026.113280_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123449","article-title":"A five-year prospective study of diabetic retinopathy progression in chinese type 2 diabetes patients with \u201cwell-controlled\u201d blood glucose","volume":"10","author":"Jin","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.diabres.2026.113280_b0020","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.scib.2023.12.053","article-title":"Ethanolamine as a biomarker and biomarker-based therapy for diabetic retinopathy in glucose-well-controlled diabetic patients","volume":"69","author":"Hu","year":"2024","journal-title":"Sci Bull"},{"issue":"8","key":"10.1016\/j.diabres.2026.113280_b0025","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/gerona\/glab339","article-title":"Albumin-corrected fructosamine predicts all-cause and non-CVD mortality among the very elderly aged 80 years or older without diabetes","volume":"77","author":"Zhou","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"10.1016\/j.diabres.2026.113280_b0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/diacare.18.4.440","article-title":"Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level","volume":"18","author":"Tahara","year":"1995","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2026.113280_b0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clinbiochem.2016.10.014","article-title":"Corrected Fructosamine improves both correlation with HbA1C and diagnostic performance","volume":"50","author":"Rodr\u00edguez-Segade","year":"2017","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.diabres.2026.113280_b0040","first-page":"338","article-title":"Clinical availability of serum fructosamine measurement in diabetic patients with uremia. use as a glycemic index in uremic diabetes","volume":"51","author":"Shoji","year":"1989","journal-title":"Nephron"},{"key":"10.1016\/j.diabres.2026.113280_b0045","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/ki.2010.193","article-title":"Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients","volume":"117","author":"Mittman","year":"2010","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"10.1016\/j.diabres.2026.113280_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057762","article-title":"Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diabres.2026.113280_b0055","article-title":"An assessment of the utility of serum fructosamine in the diagnosis and monitoring of diabetes mellitus","volume":"15","author":"John","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.diabres.2026.113280_b0060","doi-asserted-by":"crossref","DOI":"10.1155\/jdr\/9275699","article-title":"A study of the relationship between serum albumin-corrected fructosamine and type 2 diabetic retinopathy","volume":"2026","author":"Liu","year":"2026","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2026.113280_b0065","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Improving care and promoting health in populations: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S7-S12. doi:10.2337\/dc18-S001.","DOI":"10.2337\/dc18-S001"},{"issue":"9","key":"10.1016\/j.diabres.2026.113280_b0070","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"issue":"19","key":"10.1016\/j.diabres.2026.113280_b0075","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"9735","key":"10.1016\/j.diabres.2026.113280_b0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.diabres.2026.113280_b0085","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2026.113280_b0090","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jhep.2023.08.019","article-title":"Prevalence of steatotic liver disease and associated fibrosis in the United States: results from NHANES 2017-march 2020","volume":"80","author":"Luo","year":"2024","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113280_b0095","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.scib.2024.04.008","article-title":"Recent advances in diabetic retinopathy onset in glucose-well-controlled patients: from biomarker to treatment","volume":"69","author":"An","year":"2024","journal-title":"Sci Bull"},{"issue":"4","key":"10.1016\/j.diabres.2026.113280_b0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/biom12040542","article-title":"Advanced glycation end products and diabetes mellitus: mechanisms and perspectives","volume":"12","author":"Khalid","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.diabres.2026.113280_b0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001061","article-title":"Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes","volume":"8","author":"Palladino","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"10.1016\/j.diabres.2026.113280_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000599","article-title":"Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: a systematic review and meta-analysis","volume":"2","author":"Aikaeli","year":"2022","journal-title":"PLOS Glob Public Health"},{"issue":"1","key":"10.1016\/j.diabres.2026.113280_b0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001847","article-title":"Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes","volume":"9","author":"An","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2026.113280_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108880","article-title":"Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus","volume":"177","author":"Ying","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.diabres.2026.113280_b0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jcjd.2024.04.007","article-title":"Association of fructosamine levels with glycemic management in children with type 1 diabetes as determined by continuous glucose monitoring: results from the CGM TIME trial","volume":"48","author":"Verbeeten","year":"2024","journal-title":"Can J Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2026.113280_b0130","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1186\/s12967-024-05516-w","article-title":"Current landscape and comprehensive management of glycemic variability in diabetic retinopathy","volume":"22","author":"Chen","year":"2024","journal-title":"J Transl Med"},{"issue":"7","key":"10.1016\/j.diabres.2026.113280_b0135","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/IAE.0000000000003049","article-title":"Effects of glycemic variability on the progression of diabetic retinopathy among patients with type 2 diabetes","volume":"41","author":"Park","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.diabres.2026.113280_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1037186","article-title":"Advanced glycation end products in diabetic retinopathy and phytochemical therapy","volume":"9","author":"Kang","year":"2022","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.diabres.2026.113280_b0145","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1159\/000491897","article-title":"Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy","volume":"48","author":"Xu","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"10.1016\/j.diabres.2026.113280_b0150","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11892-011-0198-7","article-title":"AGEs, RAGE, and diabetic retinopathy","volume":"11","author":"Zong","year":"2011","journal-title":"Curr Diab Rep"},{"issue":"8","key":"10.1016\/j.diabres.2026.113280_b0155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14789450.2017.1352473","article-title":"Abundance matters: role of albumin in diabetes, a proteomics perspective","volume":"14","author":"Bhat","year":"2017","journal-title":"Expert Rev Proteomics"},{"issue":"4","key":"10.1016\/j.diabres.2026.113280_b0160","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biochi.2010.12.003","article-title":"The glycation of albumin: structural and functional impacts","volume":"93","author":"Rondeau","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.diabres.2026.113280_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.154991","article-title":"Glycated albumin stimulates expression of inflammatory cytokines in muscle cells","volume":"128","author":"Kravchenko","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.diabres.2026.113280_b0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00011-017-1089-4","article-title":"Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation","volume":"67","author":"Roohk","year":"2018","journal-title":"Inflamm Res: Off J Eur Histamine Res Soc [et Al,]"},{"key":"10.1016\/j.diabres.2026.113280_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.653177","article-title":"Glycated albumin triggers an inflammatory response in the human airway epithelium and causes an increase in ciliary beat frequency","volume":"12","author":"Aitken","year":"2021","journal-title":"Front Physiol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113280_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149448","article-title":"Chronic kidney disease and diabetic retinopathy in patients with type 2 diabetes","volume":"11","author":"Rodr\u00edguez-Poncelas","year":"2016","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.diabres.2026.113280_b0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1167\/iovs.61.14.25","article-title":"Anemia and diabetic kidney disease had joint effect on diabetic retinopathy among patients with type 2 diabetes","volume":"61","author":"Wang","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"19","key":"10.1016\/j.diabres.2026.113280_b0190","doi-asserted-by":"crossref","first-page":"10502","DOI":"10.3390\/ijms221910502","article-title":"Epigenetic mechanisms in type 2 diabetes retinopathy: a systematic review","volume":"22","author":"Milluzzo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"24","key":"10.1016\/j.diabres.2026.113280_b0195","doi-asserted-by":"crossref","first-page":"8778","DOI":"10.3390\/jcm14248778","article-title":"Precision medicine in diabetic retinopathy: the role of genetic and epigenetic biomarkers","volume":"14","author":"Ka\u0161telan","year":"2025","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.diabres.2026.113280_b0200","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s40618-014-0172-8","article-title":"Human genetics of diabetic retinopathy","volume":"37","author":"Tang","year":"2014","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.diabres.2026.113280_b0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/jdi.12550","article-title":"Duration of diabetes and types of diabetes therapy in japanese patients with type 2 diabetes: the Japan diabetes complication and its prevention prospective study 3 (JDCP study 3)","volume":"8","author":"Hayashino","year":"2017","journal-title":"J Diabetes Investig"},{"issue":"7","key":"10.1016\/j.diabres.2026.113280_b0210","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s13300-023-01414-4","article-title":"Real-world patterns of basal insulin use with other diabetes medications among people with type 2 diabetes between 2014 and 2020","volume":"14","author":"Schapiro","year":"2023","journal-title":"Diabetes Ther: Res Treat Educ Diabetes Relat Disord"},{"issue":"1","key":"10.1016\/j.diabres.2026.113280_b0215","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s40001-023-01431-w","article-title":"Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives","volume":"28","author":"Liu","year":"2023","journal-title":"Eur J Med Res"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:59:08Z","timestamp":1793944748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726002007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S0168822726002007"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113280","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond HbA1c: Albumin-corrected fructosamine is associated with diabetic retinopathy in well-controlled type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113280"}}